-
11 new drugs under research from innovative pharmaceutical companies are coming, and there are more than 1 billion varieties of drugs.
Time of Update: 2022-04-27
com Global New Drug R&D Database Class 1 new drugs are about to go on the market in the United States, leading the exploration of the modernization of traditional Chinese medicine In recent years, innovative drugs going overseas has become a hot topic in the pharmaceutical industry .
-
Guangzhou: The centralized procurement of 190 varieties has expired, and the transaction will be suspended!
Time of Update: 2022-04-27
According to the relevant work arrangements, the third batch of selected varieties and non-selected drugs that have expired in the national procurement module, and the 2021 pilot expansion of the expiring selected varieties and non-selected drugs in the new transaction procurement module.
-
Who can self-test when the new crown antigen self-test product is approved for marketing?
Time of Update: 2022-04-27
Check whether the antigen self-test reagent is within the shelf life, and check whether the contents of the nasal swab, sampling tube, test card, etc.
-
In 2021, the balance of medical insurance funds will reach a new high, and there will be no worries in the short term
Time of Update: 2022-04-27
Figure 4: 2018-2021 China's basic medical insurance fund (including maternity insurance) total income unit (100 million yuan) Source: National Medical Security Administration, Zhongkang Industrial Capital Research Center organized medical insurance fund expenditure in the past 4 years with a compound annual growth rate of 10.
-
Fujian adds two new branches of the National Clinical Medical Research Center
Time of Update: 2022-04-27
The reporter learned from the Fujian Provincial Department of Science and Technology on the 14th that two new branches of the National Clinical Medical Research Center have been added in Fujian .
Fujian Branch of the National Clinical Research Center for Cardiovascular Diseases .
-
The results of the selection of 87 common and chronic diseases in the Guangdong Alliance are released!
Time of Update: 2022-04-27
It is understood that after the announcement of the selection results of this centralized drug procurement, public medical institutions in the alliance area will select the selected products and fill in the pre-purchase volume for the first year as required .
-
The tertiary hospital fully trusts the township health center to help its outpatient volume increase!
Time of Update: 2022-04-27
In November of the same year, according to local media reports, the Second Affiliated Hospital of Anhui Medical University also started a five-year trusteeship for Sanhe Hospital in Feixi County, which created a close medical alliance between Feixi County Township Health Centers and tertiary hospitals.
-
The highest inspection: Deepen traceability management of hot issues of people's livelihood such as food and drug safety
Time of Update: 2022-04-27
On the 15th, the Supreme People's Procuratorate released 12 typical cases of procuratorial organs' food and drug safety public interest lawsuits, focusing on new issues in food and drug production and sales, and providing experience that can be promoted and replicated on how to handle new types of cases .
-
Henan promotes the pilot work of cross-border e-commerce retail imported drugs
Time of Update: 2022-04-26
Recently, the Henan Provincial Food and Drug Administration held a meeting to promote the pilot work of cross-border e-commerce retail imported drugs, and arranged and deployed specific tasks to promote the pilot work of cross-border e-commerce retail imports of drugs .
-
The State Food and Drug Administration and the General Administration of Customs have added Aidian Port as a border port for the import of medicinal materials
Time of Update: 2022-04-26
On March 16, 2022, the State Food and Drug Administration and the General Administration of Customs issued the "Announcement on Adding Aidian Port in Chongzuo City, Guangxi Zhuang Autonomous Region as a border port for the import of medicinal materials" .
-
Alliance of 14 provinces in Henan: Medical institutions begin to confirm the amount to be allocated
Time of Update: 2022-04-26
On March 14, Shanxi Province issued the "Notice on Carrying out the Confirmation of the Selected Varieties of the Fourteen Provinces (Autonomous Regions, Cities, and Corps) Drug Alliances to Be Distributed", requiring the medical insurance departments of each city to organize relevant medical institutions within their jurisdictions, and within the specified time The selection of to-be-allocated quantities is completed through the 14-province drug procurement alliance component system .
-
The State Food and Drug Administration has approved 17 new coronavirus antigen detection reagents
Time of Update: 2022-04-24
According to the announcement, on March 18, after review by the State Food and Drug Administration, three new coronavirus antigen detection reagent products were approved .
As of March 18, the State Food and Drug Administration has approved 17 new coronavirus antigen detection reagent products .
-
The State Food and Drug Administration has approved 12 new coronavirus antigen detection reagents
Time of Update: 2022-04-24
On March 15, after review by the State Food and Drug Administration, two new coronavirus antigen detection reagent products were approved .
As of March 16, the State Food and Drug Administration has approved 12 new coronavirus antigen detection reagent products .
-
The four departments issued the announcement of the "Quality Management Specification for the Production of Chinese Medicinal Materials"
Time of Update: 2022-04-24
The drug supervision and management department shall carry out extended inspections on corresponding Chinese herbal medicine production enterprises, and provide guidance on medicinal requirements, origin processing, and quality inspection .
-
China Resources Secco and YaoPharma Acarbose Tablets were approved on the same day
Time of Update: 2022-04-24
com, in 2020, the total sales of acarbose tablets in Chinese public medical institutions and physical pharmacies in Chinese cities will exceed 4 billion yuan, and Bayer has the largest market share .
-
The "first brother" of the pharmaceutical stock lost its market value of 400 billion, who is the most resistant to the TOP20
Time of Update: 2022-04-24
As of now, among the TOP20 pharmaceutical stocks, 9 companies, including Mindray Medical, WuXi AppTec, Hengrui Medicine, and Pien Tze Huang, have a market value of more than 100 billion yuan; only 4 have positive growth in terms of price changes.
-
The inflection point of the upside will come to the four major segments of the traditional Chinese medicine industry, waiting for the Nuggets
Time of Update: 2022-04-24
In 2021, the State Food and Drug Administration announced the first batch and the second batch of 196 national standards for traditional Chinese medicine formula granules, which put forward requirements for the quality control of traditional Chinese medicine and the management of the whole production process.
-
Qilu's firepower is full!
Time of Update: 2022-04-24
A few days ago, Qilu Pharmaceutical's R&D pipeline has made new progress: the 1st class new drug QLH11906 has been submitted for IND, and the long-acting microcrystalline preparation paliperidone
-
The fastest centralized procurement in history: a drop of 74%, and the price of the new crown self-test box plummeted
Time of Update: 2022-04-24
On March 15, the Guangdong Provincial Drug Trading Center issued the "Notice on Adjusting the Prices of the Selected Varieties of the New Coronavirus (2019-nCoV) Testing Reagent Alliance Regional Group's Procurement with Volume" .
-
Seven long-acting microsphere preparations are on the way in the Nuggets 10 billion inhalation preparation market
Time of Update: 2022-04-24
After years of market cultivation, Livzon Group's innovative drug ilaprazole series products and leuprolide acetate microspheres for injection of high-barrier complex preparations have become large varieties of 1 billion yuan .